Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $2.1 million.

  • Kewaunee Scientific's Change in Receivables rose 22560.68% to $2.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $6.5 million, marking a year-over-year increase of 118086.52%. This contributed to the annual value of $6.7 million for FY2025, which is 100931.17% up from last year.
  • Per Kewaunee Scientific's latest filing, its Change in Receivables stood at $2.1 million for Q4 2025, which was up 22560.68% from -$5.5 million recorded in Q3 2025.
  • Over the past 5 years, Kewaunee Scientific's Change in Receivables peaked at $6.3 million during Q2 2022, and registered a low of -$5.5 million during Q3 2025.
  • For the 5-year period, Kewaunee Scientific's Change in Receivables averaged around $832050.0, with its median value being $782000.0 (2021).
  • Its Change in Receivables has fluctuated over the past 5 years, first plummeted by 92400.0% in 2024, then soared by 44375.43% in 2025.
  • Over the past 5 years, Kewaunee Scientific's Change in Receivables (Quarter) stood at $2.1 million in 2021, then tumbled by 65.99% to $725000.0 in 2022, then tumbled by 72.41% to $200000.0 in 2023, then crashed by 924.0% to -$1.6 million in 2024, then soared by 225.61% to $2.1 million in 2025.
  • Its Change in Receivables stands at $2.1 million for Q4 2025, versus -$5.5 million for Q3 2025 and $4.9 million for Q2 2025.